Results 131 to 140 of about 5,871,156 (346)

Chemoresistance in Pancreatic Cancer

International Journal of Molecular Sciences, 2019
Pancreatic ductal adenocarcinoma (PDAC), generally known as pancreatic cancer (PC), ranks the fourth leading cause of cancer-related deaths in the western world.
Siyuan Zeng, M. Pöttler, B. Lan, R. Grützmann, C. Pilarsky, Hai Yang   +5 more
semanticscholar   +1 more source

Metabolism of pancreatic cancer: paving the way to better anticancer strategies

Molecular Cancer, 2020
Pancreatic cancer is currently one of the most lethal diseases. In recent years, increasing evidence has shown that reprogrammed metabolism may play a critical role in the carcinogenesis, progression, treatment and prognosis of pancreatic cancer ...
C. Qin, Gang Yang, Jinshou Yang, B. Ren, Huanyu Wang, Guangyu Chen, F. Zhao, L. You, Weibin Wang, Yupei Zhao   +9 more
semanticscholar   +1 more source

UiO‐66 metal–organic frameworks in biomedicine: From structural tunability to bioimaging, photodiagnostics, and photodynamic cancer therapy

FEBS Open Bio, EarlyView.
UiO‐66(Zr) metal–organic frameworks are chemically stable, biocompatible, and highly tunable nanomaterials. Their modular structure enables controlled drug delivery, multimodal bioimaging, and light‐activated photodynamic therapy, supporting integrated diagnostic and therapeutic (theranostic) applications in cancer and biomedical research.
Veronika Huntošová, Grigorii Rakhalskii, Miroslav Almáši   +2 more
wiley   +1 more source

Pancreatic Cancer [PDF]

Gastroenterology Research and Practice, 2015
Niccola Funel, Marco Del Chiaro, Djuna L. Cahen, Johanna Laukkarinen   +3 more
openaire   +6 more sources

Feasibility of laparoscopic versus open pancreatoduodenectomy following neoadjuvant chemotherapy for borderline resectable pancreatic cancer: a retrospective cohort study

World Journal of Surgical Oncology
Background There is no evidence supporting the feasibility of laparoscopic pancreaticoduodenectomy (LPD) compared to open pancreatoduodenectomy (OPD) following neoadjuvant chemotherapy (NACT) for pancreatic ductal adenocarcinoma (PDAC).
Zheng Li, Qifeng Zhuo, Borui Li, Mengqi Liu, Chen Chen, Yihua Shi, Wenyan Xu, Wensheng Liu, Shunrong Ji, Xianjun Yu, Xiaowu Xu   +10 more
doaj   +1 more source

Gemcitabine: Progress in the treatment of pancreatic cancer [PDF]

, 2001
Unresectable pancreatic cancer has a dismal prognosis with a median survival of 3-5 months in untreated disease. Since the introduction of gemcitabine, pancreatic cancer may no longer be regarded a chemotherapy-resistant tumor.
Heinemann, Volker
core   +1 more source

GAD65 Antibody ELISA With Extended Reportable Range: Validation and Guidance for Neurological Practice

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To (1) validate GAD65‐ELISA detection and quantification for type 1 diabetes mellitus and autoimmune neurological diagnoses, (2) correlate ELISA results (reference range < 5 IU/mL) with established radioimmunoprecipitation assay (RIA; ≤ 0.02 nmol/L), and (3) define ELISA clinical utility and pitfalls.
Andrew McKeon, Dana Olofson, Diana Anissian, Divyanshu Dubey, Eoin P. Flanagan, Max C. Herman, Sarosh R. Irani, Daniel H. Lachance, Maria A. Willrich, Sean Pittock, John R. Mills, Anastasia Zekeridou   +11 more
wiley   +1 more source

Rapid on-site evaluation (ROSE) in pancreatic cancer diagnosis. doing more with less [PDF]

, 2015
Rapid on-site evaluation (ROSE) in pancreatic cancer diagnosis: Doing more with ...
Carico, Elisabetta, Carnuccio, Antonella, DI GIULIO, Emilio, Galasso, Domenico, Giarnieri, Enrico, Mancini, Rita, Rosaria Giovagnoli, Maria   +6 more
core   +1 more source

Autoimmune pancreatitis mimicking pancreatic cancer

North American Journal of Medical Sciences, 2011
Autoimmune pancreatitis is a particular type of pancreatitis of presumed autoimmune etiology, it is an entity distinct from all others forms of chronic pancreatitis, characterized by clinical, histopathological, radiographic, serologic and therapeutic features. This benign disease resembles pancreatic carcinoma both clinically and radiographically.A 27-
Hammami, Mohamed, Noomen, Faouzi, Toumi, Omar, Harzallah, Olfa, Mahmoudi, Ammar, Kallel, Wassim, Zouari, Khadija, Hamdi, Abdelaziz   +7 more
openaire   +2 more sources

Strategies for Loading and Releasing Peptide Therapeutics in Biodegradable Carriers

Advanced Functional Materials, EarlyView.
A biodegradable carrier‐based peptide delivery system is a powerful treatment platform for diverse diseases, owing to its superior therapeutic efficacy and low toxicity. This review examines the conventional peptide‐loaded carrier fabrication process and its current limitations.
Wookyoung Jang, Ki Wan Bong
wiley   +1 more source